Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06057402
Title Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) (MagnetisMM15)
Acronym MagnetisMM15
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | CAN | AUS

Facility Status City State Zip Country Details
UC Irvine Health NOT_YET_RECRUITING Orange California 92868 United States Details
Franciscan Health NOT_YET_RECRUITING Indianapolis Indiana 46237 United States Details
Epworth Freemasons NOT_YET_RECRUITING Melbourne Victoria 3002 Australia Details
Epworth Hospital NOT_YET_RECRUITING Richmond Victoria 3121 Australia Details
Slade Pharmacy NOT_YET_RECRUITING Richmond Victoria 3121 Australia Details
Tom Baker Cancer Center RECRUITING Calgary Alberta T2N 4N2 Canada Details
Cross Cancer Institute RECRUITING Edmonton Alberta T6G 1Z2 Canada Details
McGill University Health Centre RECRUITING Montréal Quebec H4A 3J1 Canada Details
Centre Hospitalier Lyon Sud NOT_YET_RECRUITING Pierre-Bénite Rhône 69310 France Details
Hôpital Saint-Louis NOT_YET_RECRUITING Paris 75010 France Details
Nagoya City University Hospital NOT_YET_RECRUITING Nagoya Aichi 467-8602 Japan Details
Kobe City Medical Center General Hospital NOT_YET_RECRUITING Kobe Hyogo 650-0047 Japan Details
Tohoku University Hospital NOT_YET_RECRUITING Sendai-shi Miyagi 980-8574 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field